TARGET AUDIENCE

This conference is intended for practicing cardiologists, fellows-in-training, nurses, pharmacists and other members of the cardiac care team in the Asia Pacific region.

LEARNING OBJECTIVES

• Demonstrate appropriate interpretation of cardiovascular guidelines and diagnostic strategies needed in daily practice.
• Describe the best practices in the treatment of patients with heart failure.
• Identify prevention strategies for treating cardiovascular disease including CV risk assessment and managing dyslipidemia.
• Apply the latest evidence to the evaluation, medical management and surgical treatment of patients with valvular heart disease.
• Evaluate current treatment strategies in the investigation and management of coronary artery disease.
• Identify best practices for the management of patients with atrial and ventricular arrhythmias.
• Demonstrate improved ECG interpretation skills.

CONFERENCE OVERALL GOAL

The overall goal of this conference is to examine emerging trends and evidence-based strategies as well as contemporary best practices resulting in guideline-driven, practical cardiovascular prevention and management for patients with cardiovascular disease.

CONFERENCE CHAIRS

	Fred M. Kusumoto, MD, FACC Director, Heart Rhythm Services Mayo Clinic Jacksonville, FL, USA
	Kian Keong Poh, MBBChir, FACC Associate Professor, Yong Loo Lin School of Medicine, NUS Senior Consultant Cardiologist, NUHCS, Singapore Steering Committee, American College of Cardiology AIG Singapore

PLANNING COMMITTEE

	Toon Wei Lim, MBBS, FRACP, PhD Senior Consultant, Cardiac Department National University Heart Centre, Singapore Vice President, Singapore Cardiac Society Singapore
	Julian Kenrick Loh, MBBCh BAO (Hons) Consultant Cardiologist Director, Coronary Care Unit National Heart Centre Singapore Singapore
	Hean Yee Ong, MBBCh BAO, FAMS, FRCP, FACC President, Singapore Cardiac Society Singapore
	Edgar Tay, MBBS, FACC Director, Structural Heart Disease Programme Senior Consultant Cardiologist National University Heart Centre Singapore Governor, ACC Singapore Chapter Singapore
	Colin Yeo, MBBS, FRCP, DRCPSC Consultant Cardiologist, Changi General Hospital Adjunct Assistant Professor, Duke-NUS Singapore
	Tee Joo Yeo, MBBS, MRCP (UK), MCI (Singapore) Assistant Professor, Yong Loo Lin School of Medicine, NUS Consultant Cardiologist and Director, Cardiac Rehabilitation Unit National University Heart Centre Singapore Singapore

US FACULTY

	Aaron D. Kugelmass, MD, FACC Vice President, Baystate Health Medical Director, Heart and Vascular Program Chief, Division of Cardiology Professor of Medicine, University of Massachusetts-Baystate Springfield, MA, USA
	Matthew W. Martinez, MD, FACC Atlantic Health - Morristown Medical Center Gagnon Cardiovascular Institute Director, Sports Cardiology Co-Director, Chanin T. Mast Hypertrophic Cardiomyopathy Center Morristown, NJ, USA
	Paul J. Mather, MD, FACC Physician Leader, Heart Failure Disease Management, University of Pennsylvania Health System Director, Faculty Development, Division of Cardiology Professor of Clinical Medicine, Heart Failure Transplant Program Perelman School of Medicine, University of Pennsylvania Philadelphia, PA, USA
	Pamela B. Morris, MD, FACC Professor of Medicine, Cardiology Director, Seinsheimer Cardiovascular Health Program Co-Director, Women's Heart Care Medical University of South Carolina Charleston, SC, USA
	Athena Poppas, MD, FACC Vice-President, American College of Cardiology Chief, Cardiology Division Director, Lifespan Cardiovascular Institute Rhode Island, Miriam and Newport Hospitals Professor of Medicine, Brown University Providence, RI, USA
	John S. Rumsfeld, MD, PhD, FACC Chief Innovation Officer, American College of Cardiology Professor of Medicine, Cardiology University of Colorado School of Medicine Denver, CO, USA
	James D. Thomas, MD, FACC Professor of Medicine, Feinberg School of Medicine, Northwestern University Director, Center for Heart Valve Disease, Bluhm Cardiovascular Institute, Northwestern University Director of Academic Affairs, Bluhm Cardiovascular Institute, Northwestern University Co-Director, Center for Artificial Intelligence in Cardiovascular Disease, Bluhm Cardiovascular Institute, Northwestern University Past President, American Society of Echocardiography Lead Scientist for Ultrasound, NASA Chicago, IL, USA

To register for the ACC Asia Conference 2020 or the ACC Board Review Course, please click here.

Registration Rates

ACC Cardiovascular Overview and Board Review Course

Free registration to the ACC Asia Conference 2020 together with SCS 32nd Annual Scientific Meeting is included, as well as 30-day complimentary access to ACC's ACCSAP, ACC's flagship self-assessment program covering the entire field of adult clinical cardiology.

Perfect your knowledge and receive a comprehensive update of cardiovascular disease with the ACC Cardiovascular Overview and Board Review Course! Join us in April and:

• Experience a thorough review of the entire field of cardiovascular disease delivered by expert faculty members from the U.S.
• Stay engaged with a variety of presentation styles: lectures, case-based reviews, interactive case studies, and question challenges
• Get answers to your individual questions by submitting them to the faculty through an Audience Response System
• Leave the course feeling updated and confident in your knowledge of cardiovascular medicine.

Over the course of two days, faculty will guide you through intense, interactive study on:

• Adult Congenital Heart Disease
• Arrhythmias/EP
• Coronary Artery Disease
• Heart Failure
• Prevention
• Valvular Heart Disease

Goal
Anchored on the American Board of Internal Medicine (ABIM) Certification Blueprint, the overall goal of this course is to provide healthcare providers with an opportunity to review and update their knowledge and competency in the latest prevention, diagnosis, and treatment of the full spectrum of cardiovascular diseases.

Learning Objectives
Upon completion of this course, learners should be able to —

• Identify strategies for integrating diagnostic results and patient symptoms to form diagnosis of cardiovascular disease states.
• Integrate treatment and/or management decisions in the care of patients with cardiovascular disease, including heart failure, valvular disease, and ACS.
• Identify best-practice guidelines in the care of patients with cardiovascular disease.
• Recognize indicators for accurate interpretation of ECG, echo, CT scan and other diagnostic methods.
• Identify gaps in their knowledge base and focus study efforts on filling gap areas.

Target Audience
This course is intended for cardiovascular specialists, physicians and fellows-in-training who are seeking an in-depth review of general cardiology. The secondary target audience is cardiovascular team professionals, including physician assistants and advanced practice nurses.

This program will be held on Thursday and Friday, April 23-24, 2020 in the Grand Hyatt Singapore.

Click here to see the agenda.

Course Directors

	Matthew W. Martinez, MD, FACC Atlantic Health - Morristown Medical Center Gagnon Cardiovascular Institute Director, Sports Cardiology Co-Director, Chanin T. Mast Hypertrophic Cardiomyopathy Center Morristown, NJ, USA
	Patrick T. O'Gara, MD, MACC* Watkins Family Distinguished Chair in Cardiology, BWH Professor of Medicine, Harvard Medical School Boston, MA, USA *will not be onsite at course

Faculty

	Philippe Genereux, MD, FACC
	Fred M. Kusumoto, MD, FACC Director, Heart Rhythm Services Mayo Clinic Jacksonville, FL, USA
	Paul J. Mather, MD, FACC Physician Leader, Heart Failure Disease Management, University of Pennsylvania Health System Director, Faculty Development, Division of Cardiology Professor of Clinical Medicine, Heart Failure Transplant Program Perelman School of Medicine, University of Pennsylvania Philadelphia, PA, USA
	Pamela B. Morris, MD, FACC Professor of Medicine, Cardiology Director, Seinsheimer Cardiovascular Health Program Co-Director, Women's Heart Care Medical University of South Carolina Charleston, SC, USA
	Anne Marie Valente, MD, FACC Section Chief, Boston Adult Congenital Heart Disease Program, Boston Children's Hospital, Brigham and Women's Hospital Co-Director, Pregnancy and Cardiovascular Disease Program, Brigham and Women's Hospital Associate Professor of Medicine and Pediatrics, Harvard Medical School Boston, MA, USA

FIT Jeopardy: The Classic Game Show With a FIT Twist

Join us as ACC international chapter teams and Singapore local teams – each made up of three Fellows in Training (FITs) have the opportunity to test their clinical knowledge during the FIT Jeopardy sessions at the ACC Asia Conference 2020 together with the SCS 32nd Annual Scientific Meeting!

FIT Jeopardy is a friendly competition that promotes a healthy rivalry between ACC international chapters, fosters FIT engagement within the chapters and provides educational value to the contestants and audience. Participants will be quizzed on a variety of topics ranging from imaging, prevention, and intervention in an unconventional manner. There will be a panel of judges and chairs to moderate the competition.

Three local teams from Singapore and three ACC international chapters teams will compete in preliminary rounds with a final round between the winning local Singapore team and the winning ACC international chapter team. The winning team will compete at the ACC.21 competition in Atlanta in March 2021!

This competition will be held as a free pre-conference opportunity on Friday, April 24, 2020 from 5:00 pm to 9:00 pm in the Grand Hyatt Singapore.

ACC International Leadership Development Program

The American College of Cardiology's Leadership Development Program offers a half-day intensive workshop that addresses various skills and knowledge in cardiovascular leadership. The program design provides you with a broad understanding of leadership styles and skills. This program addresses diverse perspectives on critical leadership challenges while also providing an awareness of concepts and techniques relevant to leading effectively within one's own healthcare institution. The ACC often draws upon those who complete this program for future leadership roles within the College.

While strengthening leadership skills is a primary objective of the training course, the program also leverages having international leaders in the same room as an opportunity to exchange ideas and best practices. Led by ACC President, Dr. Athena Poppas and Conference Co-Chair, Kian Keong Poh, MBBChir, FACC, this interactive discussion allows attendees to provide special insight into their country's healthcare and leadership challenges. The program serves as a platform for emerging leaders in the cardiovascular community to gain a deeper understanding of the varied challenges facing the College's ever-growing international community. By connecting these emerging leaders, the program facilitates the building of professional relationships and creates new opportunities for collaboration that defy geographical distance.

This program will be held as a pre-conference opportunity on Friday, April 24, 2020 from 1:00 pm to 5:00 pm in the Grand Hyatt Singapore.

Thank you for your interest in submitting an abstract to the ACC Asia Conference 2020 together with the SCS 32nd Annual Scientific Meeting. The abstract submission site is now open and all abstracts must be submitted by 11:59 pm SGT on Tuesday, February 4, 2020.

Please ensure you have read the abstract policies and procedures and submission instructions thoroughly before submitting your abstract.

Please note: Only non-US citizens who are currently residing in Asia are eligible to submit their research.

• Download a copy of the Abstract Policies and Procedures.
• Download a copy of the Abstract Submission Instructions.

Follow the directions and be cognizant of the deadline. Given the thorough review process, only submissions recognized as complete will be considered.

Please click on the following link to begin your submission: https://podio.com/webforms/23567553/1694383

For any questions regarding your submission, please contact Robin Young at ryoung@acc.org.

Apply by February 9, 2020!

ACC is hosting an exciting event at the ACC Asia Conference 2020 together with the SCS 32nd Annual Scientific Meeting — the ACC Innovation Challenge! This ACC version of a competitive pitch competition will include the most innovative startups from around the region, who will pitch their cardiovascular product or service to a live audience and panel of key cardiology opinion leaders from the United States, Singapore, and the Asia Pacific region. Companies completing an application will be selected to present their innovative solutions based on the ingenuity of their product or offering and its ability to solve a problem or meet a critical need in cardiovascular health in ways such as, but not limited to: leveraging digital health platforms, telemedicine ideas, or wearable technologies.

The winner of the Innovation Challenge will receive an opportunity to elevate their vision through international coverage and a cash prize. This event will be a unique opportunity not only for participants but also for the audience to meet innovators who are changing the future of cardiology.

Prize Package:

• The winner will:
  • Receive a cash prize of $6,000 USD
  • Be featured on the ACC's website and social media outlets
  • Have a brief interview published in the ACC's international newsletter, distributed to over 17,000 practicing cardiologists outside of the United States

Eligibility Criteria:

• Company must have a product or service relevant to cardiovascular health
• Must be a registered company and company should have been in existence in its current form for no more than 5 years
• The innovation must be categorized as digital health/health IT or medical device
• Each company may only enter one innovation in the challenge

Application Process:

• Please click the following link to complete your application: https://podio.com/webforms/23814769/1722606
• Entries that do not comply with the instructions will not be accepted.
• Please answer each of the application questions in 250-500 words.
• Application is due no later than February 9, 2020.
• The application will be scored by a subset of the competition's reviewers using evaluation criteria.
• Finalists will be notified the week of February 24, 2020 and will be invited to participate in the Innovation Challenge – Asia.

Format of the Innovation Challenge Competition:

• Each company will have six minutes to present their innovative product/offering and then four minutes of Q&A with the panel of judges.
• Company representatives will have access to A/V for slides. Companies must present in English.
• Participating startups to submit pitch PowerPoint presentations decks by April 3, 2020 to innovationdevelopment@acc.org.

Logistics:

• The Innovation Challenge competition will take place on Saturday, April 25 at the Grand Hyatt Singapore.
• Selected startups are expected to be in Singapore the day before the competition in order to participate in practice run of challenge.
• Selected startups are responsible for all costs associated with travel to and lodging in Singapore.
• Companies selected to the competition will receive free registration for up to 3 company employees, including the Challenge presenter, to the ACC Asia Conference 2020.
• Each participating company will be scored by the panel of judges on a scale of 1-5 for the attractiveness of their product and its ability to address a critical need in the delivery, treatment, or management of cardiovascular health.

If you have any questions, please reach out to innovationdevelopment@acc.org.